BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37210178)

  • 1. Can Radiomics Bridge the Gap Between Immunotherapy and Precision Medicine in Lung Cancer?
    Delasos L; Madabhushi A; Patil PD
    J Thorac Oncol; 2023 Jun; 18(6):686-688. PubMed ID: 37210178
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradigm Shift in Lung Cancer Therapy: Imaging and Clinical Implications.
    Erasmus JJ; Truong MT
    J Thorac Imaging; 2017 Sep; 32(5):275. PubMed ID: 28832413
    [No Abstract]   [Full Text] [Related]  

  • 3. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.
    Cucchiara F; Petrini I; Romei C; Crucitta S; Lucchesi M; Valleggi S; Scavone C; Capuano A; De Liperi A; Chella A; Danesi R; Del Re M
    Pharmacol Res; 2021 Jul; 169():105643. PubMed ID: 33940185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in lung cancer: the potential of cancer stem cells in future therapies.
    Morrison BJ; Steel JC; Morris JC
    Future Oncol; 2013 May; 9(5):623-5. PubMed ID: 23647289
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study Progress of Radiomics in Precision Medicine for Lung Cancer].
    Shi Z; Zhang X; Jiang T
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):385-388. PubMed ID: 31196373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging and Precision Medicine in Lung Cancer.
    Zukotynski KA; Gerbaudo VH
    PET Clin; 2017 Jan; 12(1):53-62. PubMed ID: 27863566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning-based radiomics: pacing immunotherapy in lung cancer.
    Sverzellati N; Marrocchio C
    Lancet Digit Health; 2023 Jul; 5(7):e396-e397. PubMed ID: 37268450
    [No Abstract]   [Full Text] [Related]  

  • 8. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
    Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
    Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians.
    Zhou H; Luo Q; Wu W; Li N; Yang C; Zou L
    Front Immunol; 2023; 14():1088874. PubMed ID: 36936913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of Precision Therapy for Lung Cancer: Current State of the Art.
    Park H; Sholl LM; Hatabu H; Awad MM; Nishino M
    Radiology; 2019 Oct; 293(1):15-29. PubMed ID: 31385753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesser Known Facts of Small Cell Lung Cancer.
    Li X; Enzerra M; Smith DA; Rahnemai-Azar AA; Kikano E; Ramaiya NH
    J Comput Assist Tomogr; 2019; 43(4):584-591. PubMed ID: 30762656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific Advances in Lung Cancer 2015.
    Tsao AS; Scagliotti GV; Bunn PA; Carbone DP; Warren GW; Bai C; de Koning HJ; Yousaf-Khan AU; McWilliams A; Tsao MS; Adusumilli PS; Rami-Porta R; Asamura H; Van Schil PE; Darling GE; Ramalingam SS; Gomez DR; Rosenzweig KE; Zimmermann S; Peters S; Ignatius Ou SH; Reungwetwattana T; Jänne PA; Mok TS; Wakelee HA; Pirker R; Mazières J; Brahmer JR; Zhou Y; Herbst RS; Papadimitrakopoulou VA; Redman MW; Wynes MW; Gandara DR; Kelly RJ; Hirsch FR; Pass HI
    J Thorac Oncol; 2016 May; 11(5):613-638. PubMed ID: 27013409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype.
    Fornacon-Wood I; Faivre-Finn C; O'Connor JPB; Price GJ
    Lung Cancer; 2020 Aug; 146():197-208. PubMed ID: 32563015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer.
    Sacco JJ; Al-Akhrass H; Wilson CM
    Curr Pharm Des; 2016; 22(28):4374-85. PubMed ID: 27262325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer.
    Tunali I; Tan Y; Gray JE; Katsoulakis E; Eschrich SA; Saller J; Aerts HJWL; Boyle T; Qi J; Guvenis A; Gillies RJ; Schabath MB
    JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34409252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision radiotherapy for non-small cell lung cancer.
    Yang WC; Hsu FM; Yang PC
    J Biomed Sci; 2020 Jul; 27(1):82. PubMed ID: 32693792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics and "radi-…omics" in cancer immunotherapy: a guide for clinicians.
    Porcu M; Solinas C; Mannelli L; Micheletti G; Lambertini M; Willard-Gallo K; Neri E; Flanders AE; Saba L
    Crit Rev Oncol Hematol; 2020 Oct; 154():103068. PubMed ID: 32805498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics and deep learning in lung cancer.
    Avanzo M; Stancanello J; Pirrone G; Sartor G
    Strahlenther Onkol; 2020 Oct; 196(10):879-887. PubMed ID: 32367456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements Using Radiomics.
    Lee G; Bak SH; Lee HY; Choi JY; Park H; Lee SH; Ohno Y; Nishino M; van Beek EJR; Lee KS
    J Thorac Imaging; 2019 Mar; 34(2):103-115. PubMed ID: 30664063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.